— Know what they know.
Not Investment Advice
Also trades as: COPN.SW (SIX) · $vol 3M

CMOPF Earnings

Cosmo Pharmaceuticals N.V.
1W: -9.8% 1M: -8.6% 3M: -24.6% YTD: -54.6% 1Y: -22.4% 3Y: +60.0% 5Y: -20.8%
$63.10
-2.40 (-3.66%)
 
Weekly Expected Move ±7.0%
$54 $59 $63 $68 $72
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 43 · $1.1B mcap · 9M float · 0.0039% daily turnover · Short 76% of daily vol
Last Earnings 2026-07-23
EPS
€-0.32 (US$-0.36)
▼ Miss +0.0%
Revenue
€57M ($65M)
▲ Beat +105.0%

Estimate vs Actual

Earnings Surprise History

0/20
EPS Beats
2/20
Revenue Beats
0%
EPS Beat Rate
10%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 annual 2026-12-31 €0.14 €0.14 — €103,531,227 €103,396,218
2026-10-02 annual 2030-12-31 €20.19 €20.17 ▼ 0.02 €376,209,409 €375,754,990
2026-10-02 annual 2029-12-31 €3.17 €3.17 — €250,481,832 €250,179,277
2026-10-02 annual 2028-12-31 €1.40 €1.39 ▼ 0.01 €172,696,844 €172,483,256
2026-10-02 annual 2027-12-31 €0.60 €0.59 ▼ 0.01 €124,599,470 €124,450,004
2026-10-01 annual 2030-12-31 €20.28 €20.19 ▼ 0.09 €377,761,732 €376,209,409
2026-10-01 annual 2029-12-31 €3.19 €3.17 ▼ 0.02 €251,515,375 €250,481,832
2026-10-01 annual 2027-12-31 €0.60 €0.60 — €125,113,595 €124,599,470
2026-10-01 annual 2026-12-31 €0.14 €0.14 — €103,958,420 €103,531,227
2026-10-01 annual 2028-12-31 €1.40 €1.40 — €173,409,430 €172,696,844
2026-09-29 annual 2027-12-31 €0.60 €0.60 — €124,977,374 €125,113,595
2026-09-29 annual 2026-12-31 €0.14 €0.14 — €103,845,232 €103,958,420
2026-09-29 annual 2028-12-31 €1.40 €1.40 — €173,220,625 €173,409,430
2026-09-29 annual 2030-12-31 €20.26 €20.28 ▲ 0.02 €377,350,433 €377,761,732
2026-09-29 annual 2029-12-31 €3.18 €3.19 ▲ 0.01 €251,241,530 €251,515,375
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms